-
Mashup Score: 4Tenecteplase for stroke linked to reduced ICH risk - 2 year(s) ago
The rate of symptomatic hemorrhage after getting a thrombolytic is half that with tenecteplase than with alteplase.
Source: www.mdedge.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 7Tenecteplase for stroke linked to reduced ICH risk - 2 year(s) ago
The rate of symptomatic hemorrhage after getting a thrombolytic is half that with tenecteplase than with alteplase.
Source: www.mdedge.comCategories: Latest Headlines, NeurologyTweet-
Patients with an ischemic stroke treated with #tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage compared with those receiving alteplase. https://t.co/wZEvqvCkxj #ISC2022 https://t.co/8uH52uz71L
-
-
Mashup Score: 2
Administration of low-dose IV tenecteplase in the 4.5 to 24 hours after stroke symptom onset seemed to be safe and effective in the reperfusion and recanalization of occluded large cerebral vessels, a speaker reported.According to the results of a phase 2a trial presented at the International Stroke Conference, low-dose tenecteplase (TNKase, Genentech) was more effective in achieving the primary
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Low-dose IV #tenecteplase in the 4.5-24 hours after #stroke onset seemed to be safe and effective in the reperfusion and recanalization of occluded large cerebral vessels #ISC2022 @StrokeAHA_ASA @AHAMeetings @AHAScience @healioneurology #CardioTwitter https://t.co/0tF4MtYtc9
-
-
Mashup Score: 6
Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.
Source: directory.libsyn.comCategories: Latest Headlines, NeurologyTweet-
Neurology Podcast: In today's episode, you'll hear from Dr. Gaspard Gerschenfeld on the efficacy, safety, and outcomes of treating large vessel occlusion (LVO) #stroke with #tenecteplase before thrombectomy. Listen now! https://t.co/byZN5MqG7m https://t.co/KyjD2hZBZL
-
-
Mashup Score: 0
Purpose of Review Tenecteplase has been studied and recommended as an alternative thrombolytic agent in patients with acute stroke. A brief review of clinical trials and guidelines pertinent to our clinical decision algorithm is described. This is followed by operational steps that were made to create and implement a clinical pathway based on available evidence in which tenecteplase is used in…
Source: Neurology Clinical PracticeCategories: Latest Headlines, NeurologyTweet-
Early Experience With #Tenecteplase at a Comprehensive #Stroke Center: https://t.co/gDR3JNPtHQ #Neurology https://t.co/nxxECsqawM
-
-
Mashup Score: 11Switching to Tenecteplase for Stroke Thrombolysis: Real-World Experience and Outcomes in a Regional Stroke Network - 3 year(s) ago
Background and Purpose: Due to practical advantages, increasing trial safety data, recent Australian Guideline endorsement and local population needs we switched to tenecteplase for stroke thrombolys
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#STROKE #ESOC2021 Real-world experience after #Alteplase to #Tenecteplase switch implementation in New Zealand showed #Tenecteplase is associated with better functional outcomes (mRS 0-2 OR=2.2) and shorter door-to-needle time @Anna_Ranta https://t.co/4oXIvdHq7x https://t.co/I0xwjEFgBR
-
-
Mashup Score: 2
14643 reads The ANA launched new podcast series at ANA2019. Each month, during these 15-20 minute episodes, we’ll delve into topics such as implicit bias in the workplace & patient care, designing and implementing a global teleneurology program, unbiased metagenomic next…
Source: myana.orgCategories: Latest Headlines, NeurologyTweet-
*NEW EPISODE* #ANAInvestigates Tenecteplase in Stroke. In this episode, Dr. Michelle Johansen, a vascular neurologist at @HopkinsMedicine interviews Dr. Bruce Campbell, who has played a pivotal role in the deployment of #tenecteplase for #stroke. https://t.co/BKa3n4pVcp https://t.co/8WCj7mI9aJ
-
-
Mashup Score: 23
Background and Purpose: Accumulating evidence from randomized controlled clinical trials suggests that tenecteplase may represent an effective treatment alternative to alteplase for acute ischemic st
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#STROKE #BriefReport #SystematicReview Better recanalization rates (OR=3.05; 95%CI 1.73–5.40) and functional outcomes (3-month mRS 0-2 OR=2.06; 95%CI 1.15–3.69) in #LVO patients receiving IV thrombolysis with #Tenecteplase compared to #Alteplase https://t.co/wpnUHV9Upf https://t.co/XAbjvDA5Ar
-
-
Mashup Score: 0
Background and Purpose: Tenecteplase improved functional outcomes and reduced the requirement for endovascular thrombectomy in ischemic stroke patients with large vessel occlusion in the EXTEND-IA TN
Source: StrokeCategories: Latest Headlines, NeurologyTweet-
#STROKE Cost-Effectiveness of #Tenecteplase Before Thrombectomy for Ischemic Stroke; Analysis of EXTEND-IA TNK randomized trial https://t.co/PedW2utnQc https://t.co/DTImSkCmvu
-
-
Mashup Score: 1Stroke Thrombolysis With Tenecteplase to Reduce Spread of Coronavirus Disease 2019 and Alteplase Shortage - 4 year(s) ago
This Viewpoint advocates for expanded usage of tenecteplase in patients with stroke as a means of avoiding coronavirus disease 2019 spread and easing potential shortages of alteplase.
Source: jamanetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Saver and @warach_steven make the case, with rationale and recommendations for switching from alteplase to #tenecteplase for acute #stroke thrombolysis. https://t.co/LgeLVS4Odb
-
Patients with an ischemic stroke treated with #tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage compared with those receiving alteplase. https://t.co/Z5mMwcFVeU #ISC2022 https://t.co/nHkgxkV3Yn